Show
Sort by
-
The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine induced mouse model
-
Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models
-
Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model
-
Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice
-
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice
-
Presence of liver angiogenesis and upregulation of VEGF in a mouse mice of non-alkoholic steatohepatitis (NASH)
-
Presence of liver angiogenesis and upregulation of the vascular endothelial growth factor (VEGF) in a mice model of non-alcoholic steatohepatitis (NASH)